The Wearable Lie

HRV, consumer devices, and the data that makes men feel better while things get worse

I have patients who know their HRV score every morning. They can tell me their trend line — the rolling seven-day average, the color-coded recovery ring, the percentage that tells them whether their nervous system is ready for the day. They have spent more time understanding their wearable algorithm than they have spent in a physician’s office in the last three years. Some of them are doing exactly what the device says they should — sleeping more, training less on red days, noting the pattern. And some of them have ApoB levels that would concern me greatly, and are using the green recovery score as evidence that they don’t need a cardiology appointment.

I do not blame the device. I am genuinely glad these men are paying attention to something. The wearable created an entry point into physiological self-awareness that, for many of the men I treat, never existed before. The problem is not the tool. The problem is the gap — between what the wearable can measure and what I need to know — and the specific ease with which data, any data, can become a substitute for the question that requires a physician to answer.

This is the chapter where we talk about that gap honestly. By the time you finish it, you will understand what your device is actually measuring, what it is not measuring, and why a cardiologist looks at your excellent Oura score and remains, gently, not reassured.

What HRV Actually Is — and Why It Genuinely Matters

Heart rate variability is not a wellness concept. It is a real, clinically meaningful measure of the autonomic nervous system’s ability to respond flexibly to the demands of a given moment. Let me explain precisely what that means.

Your heart does not beat at perfectly even intervals. If it beats at exactly 60 beats per minute, that does not mean one beat per second — it means the intervals between beats fluctuate around a mean, and those fluctuations carry information. The technical term for the most clinically relevant of these measures is RMSSD: root mean square of successive differences between adjacent R-R intervals. What that jargon means in plain language is: how much does the time between your heartbeats vary, beat to beat? A heart with high RMSSD is showing high parasympathetic influence — the vagal brake is working, the nervous system is relaxed and adaptive. A heart with low RMSSD is showing sympathetic dominance — the fight-or-flight system is running, and the parasympathetic recovery system has been suppressed.

Why does this matter clinically? Because the autonomic nervous system is the interface between your psychology and your cardiovascular system. When your life is running at a chronic level of stress — cortisol elevated, sleep fragmented, emotional state suppressed — the sympathetic nervous system runs hotter than it should, and the vagal brake is chronically underused. HRV is the readout of that dynamic. A 2014 review in Frontiers in Psychology by Lehrer and Gevirtz established the mechanistic basis for this: higher HRV reflects better baroreflex sensitivity — the feedback loop that stabilizes blood pressure — and lower HRV is independently associated with hypertension, cardiac arrhythmia, and all-cause mortality. This is not a wearable company’s marketing claim. It is basic cardiac autonomic physiology that has been documented in clinical literature for decades.

A 2021 review in Nature Reviews Cardiology by Bayoumy and colleagues synthesized the state of the science: HRV-based measures provide clinically meaningful information about cardiovascular autonomic function, with lower resting HRV independently predicting incident coronary events and cardiovascular mortality in prospective cohort studies. The review noted that the evidence base is strongest for longer-term ambulatory HRV measures and that short-term consumer-grade measurement introduces significant methodological noise. That noise is where the problem begins.

What Consumer Wearables Measure — and the Gap Between That and Clinical HRV

Your Oura ring, your Whoop band, your Apple Watch — none of them measure HRV the way a clinical study measures HRV. This is worth understanding in specific terms.

Clinical HRV measurement uses electrocardiography — ECG — which detects the electrical signal generated by depolarization of the ventricular myocardium. The R-R interval in a clinical ECG is precise to the millisecond. Consumer wearables almost universally use photoplethysmography — PPG — which measures changes in blood volume in the capillary bed of the wrist or finger using green (and sometimes red or infrared) light. The light reflects off the skin; a photodetector measures how much comes back, and the variation corresponds to the pulse wave created by the heartbeat.

The difference matters because PPG-derived pulse interval and ECG-derived R-R interval are not the same thing, and the translation between them introduces error. A 2017 study published in the Journal of Personalized Medicine by Shcherbina et al. evaluated seven consumer wrist-worn devices in a diverse cohort performing multiple activities and found that heart rate accuracy varied substantially across devices and conditions, with error rates climbing significantly during physical activity. Resting measurement was better, but still not equivalent to ECG.

The proprietary algorithm problem compounds this. Every major wearable platform — Whoop, Oura, Garmin, Apple — uses its own proprietary algorithm to convert raw PPG data into an HRV score, apply noise filtering, and generate the readiness or recovery metric the user sees. These algorithms are not published. They are not independently validated in the peer-reviewed literature. A rising Whoop recovery score and a rising Oura readiness score are not measuring the same thing, and neither is measuring what a Holter monitor measures. Comparing your HRV score to a friend’s is not meaningful. Comparing your score to a population norm is not straightforward. The number that appears on your screen is a proprietary interpretation of a proxy measure.

This does not mean the trend is meaningless. If your resting HRV has been declining over six weeks and you are under more stress and sleeping worse, that trend is probably real. If you had one terrible night of sleep and your score dropped 20 points, that is probably real too. Trends within a single individual, on a single device, measured in consistent conditions, carry signal. Absolute numbers carry far less.

The Skin-Tone Accuracy Problem

There is an additional issue with PPG technology that I want to name directly, because it is relevant to the men this book serves, and because the mainstream wearable conversation has largely avoided it.

Multiple published studies have documented that green-light PPG sensors are less accurate in individuals with darker skin tones. The mechanism is straightforward: melanin absorbs green light, and higher melanin concentration reduces the signal-to-noise ratio of the optical measurement. A 2021 analysis published in NPJ Digital Medicine by Bent and colleagues found that photoplethysmography performed significantly worse in participants with darker skin, with pulse oximetry accuracy declining in a melanin-dependent fashion. The FDA issued a safety communication in 2021 acknowledging this limitation for pulse oximetry specifically.

HRV measurement via PPG inherits this problem. A darker-skinned man wearing a green-light wrist sensor may be receiving a less accurate readout than a lighter-skinned man using the same device under the same conditions. The irony, in the context of this book, is pointed: the population of men at highest cardiovascular risk from the structural burden we discuss in Chapter 11 is also the population for whom consumer wearable accuracy is most degraded. I name this not to discourage wearable use — some signal is better than no attention — but because intellectual honesty requires it. If you are a Black man using a consumer wearable as your primary physiological monitoring tool, you should know this limitation exists.

The HRV-as-Progress-Proxy Problem

Here is the pattern I see most frequently, and the one that concerns me most.

A man reads about HRV. He learns, correctly, that higher HRV is better and that his lifestyle choices — sleep, stress management, exercise recovery — influence his score. He starts improving his score. His sleep is more consistent. He is drinking less. He is taking recovery days. His wearable tells him, reliably, that these changes are working. And it is not wrong. His autonomic tone is probably improving. The interventions are genuinely valuable.

But he has not had a cardiologist visit in three years. His ApoB has never been measured. His coronary artery calcium score is unknown. His blood pressure at work — masked hypertension, elevated only under occupational stress — has never been captured. His Lp(a) is unknown. He is 46 years old.

The wearable is measuring something real. What it cannot measure is whether subclinical atherosclerosis has been accumulating in his coronary arteries for the past decade, building on a foundation of ApoB-laden particles, insulin resistance, and sleep-fragmented cortisol dysregulation that predates his wellness journey by years. It cannot measure his CAC score, which is a direct index of atherosclerotic burden. It cannot measure his ApoB, which is the strongest predictor of incident cardiovascular events across virtually every lipid management trial. It cannot see his Lp(a) — a genetically determined atherogenic lipoprotein that is elevated in approximately 20% of the population and cannot be reduced by exercise, diet, or improved sleep hygiene.

A good HRV trend is evidence that a man is taking better care of his nervous system. It is not a cardiovascular clearance.

What HRV Can Genuinely Tell You

I want to be careful here, because the point of this chapter is not to dismiss a tool that has helped men pay attention to their bodies for the first time. The point is to position the tool accurately.

These are the things consumer HRV measurement can meaningfully tell you:

Trending down over weeks means your system is under load. If your resting nighttime HRV has been declining for three to four weeks and your subjective stress is elevated, your body is telling you something consistent. The trend is likely real. Do not train through it. Address the upstream cause.

Acute drops signal physiological stress. A single night with an HRV drop of 20-30% — in the context of illness, excessive alcohol, poor sleep, or an emotionally brutal week — is a reliable signal that your autonomic system is in recovery mode. This is exactly the kind of information these devices are designed to provide, and they provide it reasonably well.

HRV biofeedback has strong evidence. This is distinct from passive monitoring. The specific practice of slow, resonance-frequency breathing — approximately 6 breaths per minute, which is roughly one inhale-exhale cycle every 10 seconds — has a well-documented clinical evidence base for improving baroreflex sensitivity and autonomic regulation. Lehrer and Gevirtz’s 2014 Frontiers in Psychology review synthesized multiple randomized controlled trials showing HRV biofeedback significantly improves resting HRV, reduces blood pressure, and improves symptoms in patients with hypertension and cardiac conditions. A wearable that supports real-time slow breathing practice with HRV feedback is providing genuine value. A wearable that tells you your readiness score for the day and allows you to feel that your cardiovascular health is being monitored is providing something more limited.

Low chronic HRV should prompt a physician conversation, not a wearable intervention. If your resting nighttime HRV has been persistently low for months — 30-35 ms on a wrist device, or below whatever your personal baseline by 15-20% — and sleep, stress, and alcohol changes have not moved it, that is a flag worth bringing to a physician. Low chronic HRV is associated with hypertension, insulin resistance, obstructive sleep apnea, and subclinical cardiovascular disease. A wearable that shows you the flag is valuable. The flag requires a physician to investigate, not a new breathing protocol.

The Missing Metrics — What No Wearable Measures

I want to give you the complete list, because it is the most important paragraph in this chapter.

Your wearable does not measure:

ApoB — the concentration of atherogenic lipoprotein particles in your blood; the strongest independent predictor of cardiovascular events in lipid management literature.

Coronary artery calcium (CAC) — a direct index of atherosclerotic plaque burden, detectable years before any clinical event, measurable for approximately $100-150 out of pocket in most cities.

High-sensitivity CRP (hs-CRP) — a systemic inflammatory biomarker that, when elevated in the range of 2-3 mg/L, identifies men at cardiovascular risk independent of their cholesterol.

Lp(a) — lipoprotein(a), a genetically determined atherogenic particle that is elevated in one in five men and is not influenced by exercise, diet, or improved sleep.

Fasting insulin and HOMA-IR — the most sensitive early markers of insulin resistance, which precede type 2 diabetes by a decade and drive accelerated atherosclerosis through endothelial dysfunction.

Testosterone and SHBG — free testosterone may be functionally low in a lean, high-achieving man whose total testosterone is technically within normal range, and low free testosterone is associated with metabolic syndrome, visceral adiposity, and cardiovascular risk.

Blood pressure under occupational stress — masked hypertension, elevated only at work, affects approximately 27% of American men and is completely invisible to office measurements and to every consumer wearable currently available.

Ankle-brachial index (ABI) — a simple measure of peripheral arterial disease that detects subclinical atherosclerosis in the leg arteries, which frequently co-occurs with coronary disease.

The wearable measures autonomic tone, sleep stages, resting heart rate, and a proxy of HRV. These are meaningful inputs to a cardiovascular health picture. They are not the picture.

The Mid-Book Honesty Point

You have now read nine chapters of this book. You know more about your cardiovascular risk profile — ApoB, CAC, cortisol curves, testosterone ratios, HRV, sleep architecture, ED as vascular warning — than most men your age know. You have, in clinical terms, a vocabulary that most men never acquire.

Here is the question I want to sit with you on for a moment: has this knowledge become a reason to act, or has it become a reason to feel like you’re handling it?

This is not a rhetorical device. It is a documented clinical phenomenon. High-achieving men are extraordinarily good at a specific kind of intellectually engaged non-action — gathering information with genuine interest, understanding it with genuine rigor, and using the gathering itself as a substitute for the physician visit, the lab order, the CAC score. I have seen this pattern more times than I can count. A man who has read every NEJM Perspectives piece on ApoB and can explain the MESA trial to you at a dinner party, who has not ordered his own ApoB level.

Information is the first step. It is not the last one. The next step is the appointment. The appointment where a physician who has read your numbers — ApoB, Lp(a), hsCRP, testosterone, fasting insulin — tells you what your actual risk profile looks like, not what your wearable algorithm calculated.

Your HRV score might be excellent. Your CAC score might be 180. These are not redundant measurements. They are measuring different things. Both could be true simultaneously.

Clinical Pearl: Heart rate variability is a real and clinically meaningful measure of autonomic health. Consumer wearables measure a proxy of HRV using light-based pulse detection, which is less accurate than ECG-based measurement, is affected by motion and ambient conditions, and — by published evidence — is less accurate in individuals with darker skin tones. A consistently good HRV trend on your wearable is a reasonable signal that your autonomic nervous system is under less load. It is not a cardiovascular clearance. The cardiologist’s required panel — ApoB, CAC, hsCRP, testosterone, fasting insulin — cannot be measured by any consumer wearable currently on the market.

The Composite Vignette

Marcus is 44. He is a senior partner at a private equity firm. He has a Whoop band and an Oura ring, and he genuinely knows what RMSSD means. His recovery score has been green for 11 consecutive days. He sleeps seven hours and wakes mostly once, which he attributes to the fact that he stopped drinking during the week. He exercises four times per week — two strength sessions, two zone-two runs. He feels better than he has in years. He has not had a cardiovascular panel run since a pre-employment physical six years ago. In that physical, his LDL was 118 mg/dL and his doctor said his cholesterol was fine. Neither he nor his doctor ordered an ApoB. Neither ordered an Lp(a). His father had a myocardial infarction at 57. Marcus is in excellent wearable health. He may or may not be in excellent cardiovascular health. Without the panel, neither he nor I can say.

Permission Paragraph

You have been paying attention. Whatever brought you to this book — a peer’s cardiac event, a number that concerned you, a morning you want to stop having — you have been attending to something your instincts told you needed attention. The wearable helped. The reading helped. The attention itself is valuable and real.

What I am asking you to do now is the harder thing: take what you have learned and bring it to a physician who can run the tests the wearable cannot. Not because the knowledge is insufficient. Because the knowledge is the preparation for the appointment, not the replacement for it. There is a specific kind of courage in making that call — not because the call is hard, but because it means accepting that the story the wearable tells might be incomplete. You are allowed to know the complete story. You have earned the right to that information. Call your doctor this week.

What to Do This Week

1. Write down, from memory, the last time you had a complete cardiovascular panel that included ApoB (not just LDL), hs-CRP, and fasting insulin. If you cannot remember, or if the answer is more than two years ago, that is the first action: schedule the blood draw. Function Health, any direct-access laboratory, or a physician order will all work.

2. For the next seven nights, note your device’s HRV readout each morning. Notice the trend. Then notice what else was happening in those seven days — sleep quality, stress level, alcohol, exercise load. The correlation teaches you more than the number alone.

3. Ask your doctor specifically about coronary artery calcium scoring. If you are between 40 and 65 and have not had a CAC score, this is a $100-150 test that provides a direct index of your atherosclerotic burden. Your HRV score has never told you that. Your CAC score will.

Transition to Chapter 10

The next chapter is about something that cardiovascular medicine has only recently been willing to call what it is — a risk factor with a measurable physiological mechanism and an effect size comparable to smoking. The word is loneliness. And among the men most likely to read this book — high-achieving, time-compressed, professionally successful — it is epidemic in a way that hides very well behind a full calendar.